Centene Corporation (CNC)
$
36.36
+0.60 (1.65%)
Key metrics
Financial statements
Free cash flow per share
2.1882
Market cap
17.6 Billion
Price to sales ratio
0.0985
Debt to equity
0.6414
Current ratio
1.0979
Income quality
0.8480
Average inventory
0
ROE
0.0753
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government-subsidized programs, including Medicaid, the State Children's Health Insurance Program, long-term services and support, foster care, and Medicare-Medicaid plans that cover dually eligible individuals, as well as aged, blind, or disabled programs. The financial data pertains to the fiscal year 2024 with a diluted EPS of $6.31 accounting for potential share dilution. The operating expenses amount to $13,654,000,000.00 encompassing various operational costs incurred by the company. The income before tax ratio is 0.03 reflecting the pre-tax margin and indicating a comprehensive financial overview. Furthermore, the EBITDA ratio is 0.04 highlighting the company's operational efficiency across its diverse offerings. Its health plans include primary
Investing in Centene Corporation (CNC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Centene Corporation stock to fluctuate between $25.08 (low) and $71.04 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-10-13, Centene Corporation's market cap is $17,857,595,880, based on 491,133,000 outstanding shares.
Compared to Eli Lilly & Co., Centene Corporation has a Lower Market-Cap, indicating a difference in performance.
To buy Centene Corporation (CNC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CNC. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Centene Corporation's last stock split was 2:1 on 2019-02-07.
Revenue: $163,071,000,000 | EPS: $6.33 | Growth: 27.36%.
Visit https://www.centene.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $98.53 (2022-08-15) | All-time low: $25.08 (2025-08-07).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
forbes.com
After a period of underperformance, Centene's stock (NYSE:CNC) has recently seen a strong rebound, rising 6% on September 24 and nearly 20% over the last month. This follows a significant drop in July 2025 after the company withdrew its 2025 financial guidance.
prnewswire.com
SACRAMENTO, Calif. , Sept. 23, 2025 /PRNewswire/ -- Following Gov.
finbold.com
While the broader S&P 500 has enjoyed a resilient 2025 with consistent record highs, some individual names have suffered heavy losses.
prnewswire.com
MECHANICSBURG, Pa. , Sept. 18, 2025 /PRNewswire/ -- PA Health & Wellness, a leading managed care organization in Pennsylvania and a company of Centene Corporation (NYSE: CNC), today announced that it has been ranked among the top 14 Medicaid health plans in the United States by the National Committee for Quality Assurance (NCQA) in its 2025 Health Plan Ratings.
prnewswire.com
Multi-year initiative aims to combat clinician burnout and improve mental health support across North Carolina's healthcare workforce DURHAM, N.C. , Sept. 16, 2025 /PRNewswire/ -- The North Carolina Clinician and Physician Retention and Well-being (NCCPRW) Consortium announced today a transformative $1.3 million grant from the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC), and Carolina Complete Health, a provider-led Medicaid health plan created by Centene, the North Carolina Medical Society, and the North Carolina Community Health Center Association.
seekingalpha.com
Centene is deeply undervalued after a 54% share price drop, yet maintains strong profitability, a solid balance sheet, and a robust market position. Temporary headwinds, including ACA revenue adjustments, rising medical costs, and withdrawn guidance, have pressured CNC, but structural strengths remain intact. Management is focused on restoring margins through contract repricing, digital transformation, and Medicaid rate negotiations, positioning CNC for recovery.
investopedia.com
U.S. equities gained at midday, with the S&P 500 and Nasdaq adding to Wednesday's latest closing record highs, as new inflation and unemployment reports boosted confidence the Federal Reserve will cut interest rates next week. The Dow Jones Industrial Average was more than 1% higher.
seekingalpha.com
Centene Corporation (NYSE:CNC ) Deutsche Bank Healthcare Summit September 11, 2025 8:00 AM EDT Company Participants Sarah London - CEO & Director Andrew Asher - Chief Financial Officer Conference Call Participants George Hill - Deutsche Bank AG, Research Division Presentation George Hill MD & Equity Research Analyst Good morning, everybody. Welcome to day 2 of the DB Healthcare Summit.
benzinga.com
Centene Corp CNC stock is rallying Thursday after the insurer confirmed its fiscal 2025 outlook of roughly $1.75 adjusted EPS—beating Wall Street's $1.69 consensus—despite having pulled prior guidance in July over preliminary actuarial data concerns.
globenewswire.com
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Centene (CNC) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Centene between December 12, 2024 to June 30, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
See all news